Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.

19 Oct 2021

NIH RADx initiative announces $77.7 million to develop new rapid COVID-19 diagnostic tests

The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19.

15 Oct 2021

Cell-based quadrivalent influenza vaccine produces sufficient immune response in children

A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study.

15 Oct 2021

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

NewsMed speaks to KNAUER about the company’s background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.

From KNAUER Wissenschaftliche Geräte GmbH 14 Oct 2021

Study finds nearly 42,000 sources of toxic "forever chemicals" that could be polluting water bodies

A new study by Environmental Working Group scientists finds almost 42,000 potential sources of the toxic "forever chemicals" known as PFAS that could be polluting surface water or drinking water in communities across the U.S.

12 Oct 2021

WHO's recommendation for malaria vaccine offers a glimmer of hope for Sub-Saharan Africa

The World Health Organization's recommendation of broad deployment of the first malaria vaccine among children in Sub-Saharan Africa has been widely celebrated, but scientists warn it could face hurdles in its acquisition and distribution by endemic countries.

12 Oct 2021

Penn Medicine's new Pavilion is set to open this month to staff, patients, and visitors

Referred to as a "Beacon of Hope," Penn Medicine's new Pavilion, one of the largest hospital projects underway in the United States, opens to staff, patients, and visitors this month.

11 Oct 2021

Acquisition of Advanced Diagnostic Laboratory LLC

ADL Health’s CLIA-certified laboratory covers the fields of clinical, forensic and microbiological tests.

From EKF Diagnostics 11 Oct 2021

West Midlands' thriving digital industries expected to create thousands of new jobs by 2025

The West Midlands has been named the country's fastest-growing tech sector and the region's thriving digital industries are expected to create thousands of new jobs by the end of 2025.

11 Oct 2021

Functionality testing in the pharmaceutical and medical sectors

In this interview, News-Medical talks to ZwickRoell UK about materials testing in the pharmaceutical and medical industry.

From ZwickRoell GmbH Co. KG 7 Oct 2021

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

A new study posted to the medRxiv* server and led by Dr. Mattia D'Agostino, Dr. Eleonora Pavoni and Dr. Alice Romagnoli from the Polytechnic University of Marche in Ancona (Italy), a gFET biosensor that uses angiotensin-converting enzyme 2 (ACE2) as a bioreceptor has been put forth as a viable solution.

6 Oct 2021

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Researchers at the Centre for Genomic Regulation and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created the treatment by removing a common bacteria's ability to cause disease and repurposing it to attack harmful microbes instead.

6 Oct 2021

New low-cost ventilator could address the shortage of ventilators in developing countries

A new low-cost ventilator design invented during COVID-19 could address the global shortage of ventilators for other respiratory diseases.

5 Oct 2021

Researchers launch new study of COVID-19 vaccination schedules in 12-to-16-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16.

4 Oct 2021

Streamlining chemical synthesis and process development with Radleys Mya 4

In this interview, News-Medical talks to Patrick Gilbert, Technical Director at Purolite, about the work Purolite do and how their chemical synthesis processes are benefitted by the Radleys Mya 4 reaction station.

From Radleys 4 Oct 2021

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.

1 Oct 2021

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

Gyros Protein Technologies AB today announced the introduction of Gyrolab® AAV9 Titer Kit for rapid determination of titer in AAV9 vector-based cell and gene therapy manufacturing.

From Gyros Protein Technologies AB 30 Sep 2021

Researchers supplement synthetic biology toolkit to streamline investigations into genetic code expansion

One of modern biologists' most ambitious goals is to learn how to expand or otherwise modify the genetic code of life on Earth, in order to make new, artificial life forms.

30 Sep 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.